| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transforming Growth Factor beta | 48 | 2021 | 384 | 8.530 |
Why?
|
| Epithelial-Mesenchymal Transition | 16 | 2022 | 135 | 4.690 |
Why?
|
| RNA-Binding Proteins | 15 | 2022 | 215 | 3.640 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 12 | 2016 | 62 | 2.880 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 9 | 2022 | 32 | 2.660 |
Why?
|
| Apoptosis Regulatory Proteins | 17 | 2020 | 100 | 2.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2021 | 756 | 2.140 |
Why?
|
| DNA-Binding Proteins | 13 | 2021 | 700 | 2.060 |
Why?
|
| RNA, Long Noncoding | 4 | 2021 | 54 | 2.020 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 307 | 1.860 |
Why?
|
| Signal Transduction | 27 | 2021 | 2689 | 1.840 |
Why?
|
| Breast Neoplasms | 6 | 2022 | 1536 | 1.820 |
Why?
|
| Apoptosis | 14 | 2016 | 1641 | 1.660 |
Why?
|
| Cytokines | 5 | 2019 | 866 | 1.660 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2009 | 411 | 1.490 |
Why?
|
| Neoplasm Metastasis | 8 | 2018 | 306 | 1.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2020 | 214 | 1.240 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 369 | 1.190 |
Why?
|
| Membrane Proteins | 6 | 2016 | 617 | 1.170 |
Why?
|
| Neoplasms | 10 | 2020 | 1667 | 1.170 |
Why?
|
| Wnt Proteins | 5 | 2012 | 57 | 1.150 |
Why?
|
| 3' Untranslated Regions | 4 | 2016 | 56 | 1.120 |
Why?
|
| Binding Sites | 7 | 2021 | 631 | 1.090 |
Why?
|
| Animals | 63 | 2022 | 20881 | 1.080 |
Why?
|
| Transcriptional Activation | 7 | 2018 | 226 | 1.080 |
Why?
|
| RNA, Messenger | 14 | 2018 | 1664 | 1.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2018 | 43 | 1.070 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2016 | 194 | 1.060 |
Why?
|
| Mice | 33 | 2022 | 8474 | 0.960 |
Why?
|
| Autophagy | 2 | 2016 | 208 | 0.950 |
Why?
|
| Cell Line, Tumor | 14 | 2022 | 1851 | 0.930 |
Why?
|
| Melanoma | 2 | 2018 | 335 | 0.920 |
Why?
|
| beta Catenin | 5 | 2012 | 73 | 0.920 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 284 | 0.900 |
Why?
|
| Cell Movement | 8 | 2017 | 630 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2016 | 331 | 0.840 |
Why?
|
| Repressor Proteins | 4 | 2009 | 183 | 0.840 |
Why?
|
| Protein Binding | 12 | 2021 | 1027 | 0.830 |
Why?
|
| Glycoproteins | 6 | 2004 | 238 | 0.790 |
Why?
|
| DNA | 8 | 2022 | 597 | 0.790 |
Why?
|
| Poly C | 1 | 2021 | 9 | 0.780 |
Why?
|
| Genomic Instability | 1 | 2021 | 41 | 0.760 |
Why?
|
| Cell Line | 21 | 2018 | 1752 | 0.760 |
Why?
|
| Carrier Proteins | 5 | 2016 | 597 | 0.740 |
Why?
|
| Transfection | 17 | 2017 | 782 | 0.730 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 213 | 0.710 |
Why?
|
| Trans-Activators | 7 | 2004 | 237 | 0.700 |
Why?
|
| Fibronectins | 6 | 2005 | 130 | 0.690 |
Why?
|
| RNA Precursors | 2 | 2017 | 14 | 0.690 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2019 | 8 | 0.660 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2018 | 6 | 0.630 |
Why?
|
| Protein Biosynthesis | 8 | 2017 | 181 | 0.620 |
Why?
|
| Molecular Chaperones | 5 | 2004 | 81 | 0.620 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 271 | 0.610 |
Why?
|
| Humans | 55 | 2022 | 68618 | 0.600 |
Why?
|
| Phosphorylation | 15 | 2017 | 1200 | 0.600 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 39 | 0.600 |
Why?
|
| Golgi Apparatus | 1 | 2017 | 75 | 0.590 |
Why?
|
| Epithelial Cells | 9 | 2019 | 431 | 0.580 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 235 | 0.580 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2017 | 28 | 0.580 |
Why?
|
| Alternative Splicing | 1 | 2017 | 93 | 0.570 |
Why?
|
| Gene Expression Regulation | 7 | 2012 | 1293 | 0.570 |
Why?
|
| Receptors, Transforming Growth Factor beta | 8 | 2017 | 56 | 0.570 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 148 | 0.560 |
Why?
|
| Base Sequence | 7 | 2021 | 1015 | 0.550 |
Why?
|
| Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2016 | 5 | 0.550 |
Why?
|
| Cathepsin B | 1 | 2016 | 33 | 0.540 |
Why?
|
| Chromosomal Instability | 1 | 2016 | 14 | 0.540 |
Why?
|
| Mesoderm | 5 | 2010 | 231 | 0.540 |
Why?
|
| Zebrafish Proteins | 2 | 2009 | 100 | 0.530 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 15 | 0.520 |
Why?
|
| Sequence Analysis, Protein | 1 | 2015 | 16 | 0.520 |
Why?
|
| Inhibin-beta Subunits | 1 | 2015 | 4 | 0.520 |
Why?
|
| Databases, Protein | 1 | 2015 | 49 | 0.510 |
Why?
|
| Mice, Inbred NOD | 4 | 2019 | 138 | 0.470 |
Why?
|
| Transcription, Genetic | 10 | 2017 | 562 | 0.460 |
Why?
|
| Growth Inhibitors | 5 | 1998 | 33 | 0.450 |
Why?
|
| Cells, Cultured | 15 | 2018 | 2673 | 0.450 |
Why?
|
| Nucleic Acid Conformation | 3 | 2021 | 92 | 0.440 |
Why?
|
| Up-Regulation | 8 | 2018 | 682 | 0.430 |
Why?
|
| Cell Division | 10 | 2004 | 541 | 0.420 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2012 | 8 | 0.410 |
Why?
|
| Clathrin | 1 | 2012 | 17 | 0.410 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 57 | 0.390 |
Why?
|
| Serine | 2 | 2016 | 99 | 0.390 |
Why?
|
| Ubiquitin | 3 | 2022 | 74 | 0.390 |
Why?
|
| Smad3 Protein | 3 | 2008 | 33 | 0.390 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2011 | 3 | 0.380 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 19 | 0.380 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 1173 | 0.380 |
Why?
|
| Phosphoproteins | 3 | 2009 | 202 | 0.380 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2008 | 56 | 0.370 |
Why?
|
| Bcl-2-Like Protein 11 | 5 | 2009 | 11 | 0.370 |
Why?
|
| Cell Nucleus | 6 | 2010 | 305 | 0.370 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 2010 | 2 | 0.370 |
Why?
|
| Hepatocytes | 2 | 2009 | 205 | 0.360 |
Why?
|
| Tumor Cells, Cultured | 10 | 2017 | 852 | 0.360 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 498 | 0.360 |
Why?
|
| Cell Cycle | 5 | 1998 | 312 | 0.360 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 12 | 0.350 |
Why?
|
| Protein Phosphatase 1 | 2 | 2009 | 36 | 0.350 |
Why?
|
| Transforming Growth Factors | 4 | 1990 | 12 | 0.350 |
Why?
|
| Promoter Regions, Genetic | 7 | 2009 | 615 | 0.350 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 15 | 0.340 |
Why?
|
| RNA Interference | 5 | 2017 | 266 | 0.330 |
Why?
|
| HEK293 Cells | 4 | 2017 | 326 | 0.330 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 94 | 0.320 |
Why?
|
| G1 Phase | 4 | 1998 | 42 | 0.320 |
Why?
|
| RNA, Small Interfering | 4 | 2016 | 434 | 0.310 |
Why?
|
| Carcinoma, Embryonal | 1 | 2007 | 4 | 0.300 |
Why?
|
| Female | 14 | 2022 | 38074 | 0.300 |
Why?
|
| Gene Expression | 7 | 2010 | 770 | 0.300 |
Why?
|
| RNA, Transfer | 2 | 2018 | 10 | 0.300 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 102 | 0.300 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 80 | 0.300 |
Why?
|
| Epithelium | 3 | 2005 | 172 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 629 | 0.290 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 328 | 0.290 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 199 | 0.290 |
Why?
|
| Caco-2 Cells | 2 | 2017 | 37 | 0.290 |
Why?
|
| Response Elements | 2 | 2012 | 29 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2018 | 320 | 0.280 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 1033 | 0.280 |
Why?
|
| Models, Biological | 4 | 2021 | 981 | 0.280 |
Why?
|
| Axin Protein | 4 | 2009 | 6 | 0.280 |
Why?
|
| Transcription Factor AP-1 | 3 | 2004 | 61 | 0.270 |
Why?
|
| Mice, SCID | 2 | 2017 | 238 | 0.270 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2005 | 34 | 0.250 |
Why?
|
| Recombinant Proteins | 6 | 2016 | 742 | 0.250 |
Why?
|
| Immunoprecipitation | 5 | 2016 | 132 | 0.250 |
Why?
|
| CD40 Antigens | 2 | 2003 | 9 | 0.240 |
Why?
|
| GTP-Binding Proteins | 3 | 1990 | 231 | 0.240 |
Why?
|
| Protein Isoforms | 3 | 2011 | 246 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2005 | 61 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 282 | 0.240 |
Why?
|
| Protein Stability | 2 | 2022 | 90 | 0.230 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1174 | 0.230 |
Why?
|
| CDC2 Protein Kinase | 3 | 1993 | 13 | 0.230 |
Why?
|
| B-Lymphocytes | 2 | 2008 | 329 | 0.230 |
Why?
|
| Blotting, Western | 6 | 2016 | 954 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2022 | 89 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.230 |
Why?
|
| Mink | 8 | 1999 | 12 | 0.220 |
Why?
|
| Mammary Glands, Animal | 2 | 2016 | 71 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2018 | 447 | 0.210 |
Why?
|
| Protein Transport | 4 | 2017 | 280 | 0.210 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2000 | 58 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 250 | 0.200 |
Why?
|
| Nucleotide Motifs | 1 | 2021 | 9 | 0.200 |
Why?
|
| Mutation Rate | 1 | 2021 | 11 | 0.200 |
Why?
|
| Virulence Factors, Bordetella | 3 | 1990 | 60 | 0.200 |
Why?
|
| Pertussis Toxin | 3 | 1990 | 72 | 0.190 |
Why?
|
| Mutation | 3 | 2021 | 1213 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 561 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 175 | 0.190 |
Why?
|
| Blotting, Northern | 5 | 2005 | 189 | 0.190 |
Why?
|
| A549 Cells | 2 | 2017 | 50 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1999 | 114 | 0.180 |
Why?
|
| Genes, Reporter | 5 | 2007 | 191 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 174 | 0.180 |
Why?
|
| DNA Damage | 1 | 2021 | 190 | 0.180 |
Why?
|
| COS Cells | 4 | 2010 | 155 | 0.180 |
Why?
|
| Proto-Oncogenes | 2 | 1990 | 37 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2005 | 376 | 0.170 |
Why?
|
| Caspase 3 | 2 | 2016 | 233 | 0.170 |
Why?
|
| Tumor Escape | 2 | 2017 | 37 | 0.170 |
Why?
|
| Zebrafish | 2 | 2012 | 187 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 2791 | 0.170 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 420 | 0.170 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.170 |
Why?
|
| Protein Domains | 2 | 2017 | 74 | 0.170 |
Why?
|
| Mice, Knockout | 5 | 2017 | 1692 | 0.170 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 13 | 0.170 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1999 | 33 | 0.170 |
Why?
|
| Caspases | 1 | 1999 | 194 | 0.160 |
Why?
|
| Clusterin | 5 | 2004 | 13 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 1998 | 60 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 82 | 0.160 |
Why?
|
| Endothelial Cells | 3 | 2007 | 384 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.160 |
Why?
|
| Caspase Inhibitors | 1 | 1998 | 36 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 86 | 0.160 |
Why?
|
| Cytoplasm | 3 | 2010 | 155 | 0.160 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 1996 | 17 | 0.160 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1998 | 73 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 114 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2005 | 140 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2017 | 368 | 0.150 |
Why?
|
| Matrix Metalloproteinases | 1 | 2000 | 223 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2017 | 14 | 0.150 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2017 | 22 | 0.150 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 13 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2017 | 63 | 0.150 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 51 | 0.150 |
Why?
|
| Exons | 1 | 2017 | 122 | 0.150 |
Why?
|
| Disease Progression | 2 | 2018 | 1038 | 0.150 |
Why?
|
| Enzyme Inhibitors | 4 | 2005 | 659 | 0.140 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 22 | 0.140 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1034 | 0.140 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2017 | 21 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1994 | 78 | 0.140 |
Why?
|
| Schizosaccharomyces | 1 | 2017 | 31 | 0.140 |
Why?
|
| Cilia | 1 | 2017 | 94 | 0.140 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2017 | 31 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 94 | 0.140 |
Why?
|
| Culture Media, Conditioned | 3 | 2005 | 78 | 0.140 |
Why?
|
| HT29 Cells | 1 | 2016 | 42 | 0.140 |
Why?
|
| Endoderm | 2 | 2007 | 37 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 95 | 0.140 |
Why?
|
| Transcriptome | 1 | 2017 | 164 | 0.130 |
Why?
|
| Cadherins | 3 | 2016 | 93 | 0.130 |
Why?
|
| HCT116 Cells | 1 | 2016 | 63 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 160 | 0.130 |
Why?
|
| Genes, ras | 2 | 1994 | 46 | 0.130 |
Why?
|
| Time Factors | 5 | 2005 | 4655 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 1996 | 317 | 0.130 |
Why?
|
| Tretinoin | 2 | 2007 | 92 | 0.130 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 756 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 322 | 0.130 |
Why?
|
| Autoantigens | 1 | 2016 | 91 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 56 | 0.130 |
Why?
|
| Lysosomes | 1 | 2016 | 136 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2003 | 902 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2016 | 124 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 77 | 0.130 |
Why?
|
| Embryonic Development | 2 | 2007 | 100 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 118 | 0.130 |
Why?
|
| NIH 3T3 Cells | 3 | 2017 | 65 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2016 | 138 | 0.120 |
Why?
|
| Vimentin | 2 | 2016 | 47 | 0.120 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 206 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 532 | 0.120 |
Why?
|
| Smad2 Protein | 4 | 2016 | 42 | 0.120 |
Why?
|
| Phenotype | 1 | 2017 | 947 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 332 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2016 | 483 | 0.110 |
Why?
|
| Ceramides | 1 | 2017 | 578 | 0.110 |
Why?
|
| Neuropilin-2 | 1 | 2013 | 19 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 108 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 375 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 507 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 331 | 0.100 |
Why?
|
| Extracellular Matrix | 2 | 2000 | 493 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2012 | 219 | 0.100 |
Why?
|
| Myosin Type II | 1 | 2011 | 2 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 1990 | 248 | 0.100 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2077 | 0.100 |
Why?
|
| Peptide Biosynthesis, Nucleic Acid-Independent | 1 | 2011 | 1 | 0.100 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 1447 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 300 | 0.090 |
Why?
|
| E-Selectin | 2 | 2007 | 44 | 0.090 |
Why?
|
| Polyribosomes | 1 | 2010 | 24 | 0.090 |
Why?
|
| Endocytosis | 1 | 2010 | 113 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 100 | 0.090 |
Why?
|
| Cholera Toxin | 1 | 1989 | 30 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2009 | 25 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 63 | 0.090 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 10 | 0.080 |
Why?
|
| Smad7 Protein | 2 | 2017 | 11 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2003 | 791 | 0.080 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2009 | 5 | 0.080 |
Why?
|
| Integrins | 2 | 2005 | 115 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2004 | 230 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2009 | 119 | 0.080 |
Why?
|
| Cell Adhesion | 3 | 2006 | 324 | 0.080 |
Why?
|
| Mutagenesis | 2 | 2000 | 60 | 0.080 |
Why?
|
| Forecasting | 1 | 2009 | 277 | 0.080 |
Why?
|
| Cell Death | 1 | 2009 | 329 | 0.080 |
Why?
|
| Smad4 Protein | 2 | 2016 | 10 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 175 | 0.070 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 15 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 626 | 0.070 |
Why?
|
| Plasmids | 2 | 2005 | 258 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 27 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2017 | 525 | 0.070 |
Why?
|
| Insulin | 1 | 2010 | 619 | 0.070 |
Why?
|
| Sequence Deletion | 2 | 1997 | 89 | 0.070 |
Why?
|
| Leukocytes | 1 | 2006 | 99 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 88 | 0.070 |
Why?
|
| Cyclins | 2 | 1998 | 50 | 0.070 |
Why?
|
| Dimerization | 2 | 2003 | 99 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 157 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 371 | 0.070 |
Why?
|
| Cell Communication | 1 | 2006 | 116 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2005 | 12 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 710 | 0.070 |
Why?
|
| Chromones | 1 | 2005 | 33 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1999 | 195 | 0.070 |
Why?
|
| Interleukin-3 | 1 | 2005 | 63 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 71 | 0.070 |
Why?
|
| DNA Primers | 2 | 1996 | 302 | 0.070 |
Why?
|
| Genes, MHC Class II | 2 | 1997 | 29 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 69 | 0.060 |
Why?
|
| Morpholines | 1 | 2005 | 79 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2005 | 447 | 0.060 |
Why?
|
| Kinetics | 3 | 2004 | 1047 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 807 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 92 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 123 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 1083 | 0.060 |
Why?
|
| Ethers | 1 | 2004 | 13 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 166 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2005 | 137 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 1204 | 0.060 |
Why?
|
| Protamine Kinase | 2 | 1994 | 3 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 63 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 67 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2004 | 765 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 1997 | 241 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2017 | 95 | 0.060 |
Why?
|
| Thrombin | 1 | 2004 | 117 | 0.060 |
Why?
|
| Dishevelled Proteins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Wnt3 Protein | 1 | 2003 | 3 | 0.060 |
Why?
|
| Wnt-5a Protein | 1 | 2003 | 5 | 0.060 |
Why?
|
| Retinoids | 1 | 2004 | 122 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 163 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2003 | 51 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 132 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 200 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cell Wall | 1 | 2022 | 21 | 0.050 |
Why?
|
| Luciferases | 2 | 2007 | 105 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.050 |
Why?
|
| RNA | 1 | 2003 | 171 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2004 | 432 | 0.050 |
Why?
|
| Guanosine Triphosphate | 2 | 1993 | 65 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 89 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.050 |
Why?
|
| Rats | 2 | 2010 | 5300 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 1 | 2022 | 171 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 172 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2004 | 251 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2000 | 40 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2020 | 40 | 0.050 |
Why?
|
| Immunity | 1 | 2020 | 67 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2000 | 230 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 91 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1745 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 481 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 434 | 0.040 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1999 | 6 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1999 | 144 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 1997 | 270 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 150 | 0.040 |
Why?
|
| Thymidine | 1 | 1998 | 32 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 85 | 0.040 |
Why?
|
| Vitamin E | 2 | 1996 | 55 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 397 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1998 | 160 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 1996 | 33 | 0.040 |
Why?
|
| Mycobacterium smegmatis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 643 | 0.040 |
Why?
|
| Protein Kinases | 1 | 1998 | 122 | 0.040 |
Why?
|
| Astrocytoma | 2 | 1997 | 30 | 0.040 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2017 | 29 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 231 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 30 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 204 | 0.040 |
Why?
|
| Phosphates | 1 | 2017 | 72 | 0.040 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2017 | 62 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 44 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 196 | 0.040 |
Why?
|
| Collagen | 2 | 2010 | 636 | 0.040 |
Why?
|
| Lipoproteins, LDL | 2 | 1996 | 343 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 57 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 160 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1996 | 5 | 0.030 |
Why?
|
| Lysophosphatidylcholines | 1 | 1996 | 11 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 53 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 85 | 0.030 |
Why?
|
| Growth Substances | 2 | 1989 | 77 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 100 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 36 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 70 | 0.030 |
Why?
|
| Clone Cells | 1 | 1996 | 67 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 261 | 0.030 |
Why?
|
| ErbB Receptors | 2 | 1996 | 239 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 88 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1996 | 6 | 0.030 |
Why?
|
| Dioxoles | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Umbilical Veins | 2 | 2007 | 54 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 68 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1996 | 114 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 492 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 357 | 0.030 |
Why?
|
| Cisplatin | 1 | 2016 | 192 | 0.030 |
Why?
|
| Placenta | 1 | 1996 | 101 | 0.030 |
Why?
|
| Benzamides | 1 | 2016 | 156 | 0.030 |
Why?
|
| S Phase | 1 | 1994 | 38 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 546 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1995 | 137 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 173 | 0.030 |
Why?
|
| Angioplasty, Balloon | 1 | 1995 | 110 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1174 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1993 | 17 | 0.030 |
Why?
|
| Microinjections | 1 | 1993 | 130 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 940 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 294 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2550 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1990 | 90 | 0.030 |
Why?
|
| Genes, myc | 1 | 1992 | 26 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 144 | 0.030 |
Why?
|
| Cattle | 1 | 1993 | 475 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1990 | 45 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 52 | 0.020 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1991 | 2 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 1991 | 14 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2010 | 7 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2010 | 15 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2010 | 33 | 0.020 |
Why?
|
| Troponin I | 1 | 2010 | 34 | 0.020 |
Why?
|
| Endosomes | 1 | 2010 | 45 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 33 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 150 | 0.020 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 176 | 0.020 |
Why?
|
| Histones | 1 | 1991 | 111 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1990 | 25 | 0.020 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 1989 | 4 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 1989 | 8 | 0.020 |
Why?
|
| Pregnancy | 1 | 1996 | 2334 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1989 | 35 | 0.020 |
Why?
|
| Thionucleotides | 1 | 1989 | 21 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1990 | 66 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2010 | 87 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1990 | 80 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1989 | 32 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 1989 | 46 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 216 | 0.020 |
Why?
|
| Male | 5 | 2017 | 37321 | 0.020 |
Why?
|
| NAD | 1 | 1989 | 73 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1070 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2004 | 778 | 0.020 |
Why?
|
| Dactinomycin | 2 | 2004 | 31 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 40 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 159 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2006 | 35 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 189 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2010 | 738 | 0.020 |
Why?
|
| Brain | 1 | 1996 | 2176 | 0.020 |
Why?
|
| Rabbits | 2 | 1996 | 509 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2004 | 3 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 32 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 48 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2004 | 22 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 30 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 95 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2004 | 19 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2004 | 91 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 147 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 55 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 317 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1982 | 284 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.010 |
Why?
|
| Peptides | 1 | 1982 | 455 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 21 | 0.010 |
Why?
|
| Tetracycline | 1 | 1997 | 29 | 0.010 |
Why?
|
| Digitonin | 1 | 1996 | 5 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 59 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1996 | 48 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 138 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 173 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1996 | 38 | 0.010 |
Why?
|
| Tunica Intima | 1 | 1995 | 59 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 89 | 0.010 |
Why?
|
| Muscle Development | 1 | 1995 | 31 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1995 | 94 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1995 | 139 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1995 | 411 | 0.010 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 1993 | 4 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 26 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1993 | 41 | 0.010 |
Why?
|
| Aorta | 1 | 1995 | 316 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 199 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 948 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1989 | 95 | 0.010 |
Why?
|
| Interphase | 1 | 1982 | 19 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1982 | 181 | 0.000 |
Why?
|